APA (7th ed.) Citation

Guillet, B., Yan, S., Hooper, B., Drelich, D., Steenkamp, J., Tomic, R., & Mancuso, M. E. (2024). Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B. Advances in therapy, 41(2), 649-658. https://doi.org/10.1007/s12325-023-02745-1

Chicago Style (17th ed.) Citation

Guillet, Benoit, Songkai Yan, Becky Hooper, Douglass Drelich, Jason Steenkamp, Radovan Tomic, and Maria Elisa Mancuso. "Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B." Advances in Therapy 41, no. 2 (2024): 649-658. https://doi.org/10.1007/s12325-023-02745-1.

MLA (9th ed.) Citation

Guillet, Benoit, et al. "Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B." Advances in Therapy, vol. 41, no. 2, 2024, pp. 649-658, https://doi.org/10.1007/s12325-023-02745-1.